BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2182116)

  • 1. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
    Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
    Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
    Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
    J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity purification of the HIV-1 protease.
    Heimbach JC; Garsky VM; Michelson SR; Dixon RA; Sigal IS; Darke PL
    Biochem Biophys Res Commun; 1989 Nov; 164(3):955-60. PubMed ID: 2686642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies.
    Cheng YS; McGowan MH; Kettner CA; Schloss JV; Erickson-Viitanen S; Yin FH
    Gene; 1990 Mar; 87(2):243-8. PubMed ID: 2158928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose.
    Rittenhouse J; Turon MC; Helfrich RJ; Albrecht KS; Weigl D; Simmer RL; Mordini F; Erickson J; Kohlbrenner WE
    Biochem Biophys Res Commun; 1990 Aug; 171(1):60-6. PubMed ID: 2203350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli.
    Strickler JE; Gorniak J; Dayton B; Meek T; Moore M; Magaard V; Malinowski J; Debouck C
    Proteins; 1989; 6(2):139-54. PubMed ID: 2695927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.
    Pichuantes S; Babé LM; Barr PJ; DeCamp DL; Craik CS
    J Biol Chem; 1990 Aug; 265(23):13890-8. PubMed ID: 2199446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
    Margolin N; Heath W; Osborne E; Lai M; Vlahos C
    Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
    Matayoshi ED; Wang GT; Krafft GA; Erickson J
    Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification, assay and kinetic features of HIV-1 proteinase.
    Billich A; Hammerschmid F; Winkler G
    Biol Chem Hoppe Seyler; 1990 Mar; 371(3):265-72. PubMed ID: 2187485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.
    Sawyer TK; Staples DJ; Liu L; Tomasselli AG; Hui JO; O'Connell K; Schostarez H; Hester JB; Moon J; Howe WJ
    Int J Pept Protein Res; 1992; 40(3-4):274-81. PubMed ID: 1478785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of HIV-1 wild-type protease and characterization of proteolytically inactive HIV-1 protease mutants by pepstatin A affinity chromatography.
    Wondrak EM; Louis JM; Mora PT; Oroszlan S
    FEBS Lett; 1991 Mar; 280(2):347-50. PubMed ID: 2013336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.
    Meek TD; Dayton BD; Metcalf BW; Dreyer GB; Strickler JE; Gorniak JG; Rosenberg M; Moore ML; Magaard VW; Debouck C
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1841-5. PubMed ID: 2648384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.
    Copeland TD; Wondrak EM; Tozser J; Roberts MM; Oroszlan S
    Biochem Biophys Res Commun; 1990 May; 169(1):310-4. PubMed ID: 2190554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromophoric peptide substrates for the spectrophotometric assay of HIV-1 protease.
    Tomaszek TA; Magaard VW; Bryan HG; Moore ML; Meek TD
    Biochem Biophys Res Commun; 1990 Apr; 168(1):274-80. PubMed ID: 2183799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1.
    Konvalinka J; Strop P; Velek J; Cerna V; Kostka V; Phylip LH; Richards AD; Dunn BM; Kay J
    FEBS Lett; 1990 Jul; 268(1):35-8. PubMed ID: 2200711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 18O isotope exchange.
    Hyland LJ; Tomaszek TA; Roberts GD; Carr SA; Magaard VW; Bryan HL; Fakhoury SA; Moore ML; Minnich MD; Culp JS
    Biochemistry; 1991 Aug; 30(34):8441-53. PubMed ID: 1883830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.